Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC29A4P2 (solute carrier family 29 member 4 pseudogene 2) is a pseudogene annotated in the human genome. Unlike protein-coding genes of the SLC29 family (such as SLC29A4, which encodes the equilibrative nucleoside transporter 4, and is implicated in monoamine and nucleoside transport relevant to neurological functions), SLC29A4P2 does not produce a functional protein and thus has no established biological role, disease association, or drug targeting relevance. The presence of “pseudogene” in its designation means it represents a genomic remnant with sequence similarity to SLC29A4 but lacks the capacity to encode a transporter or other protein product[2][6][8]. This entry is considered not a valid molecular target for therapy, research, or diagnostic purposes. If your interest is in active transporter proteins, examine related functional homologs such as SLC29A4 (Equilibrative nucleoside transporter 4, ENT4)[5][7][9], or other SLC29 family members.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 29 member 4 pseudogene 2 (SLC29A4P2).